Regulatory Effects of HMG CoA Reductase Inhibitor and Fish Oils on Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Male Subjects With Dyslipidemia - Chan, Dick C.; Watts, Gerald F.; Barrett, P. Hugh R.; Beilin, Lawrence J.; Redgrave, Trevor G.; Mori, Trevor A. (Diabetes (New York, N.Y.), 2002)
Keywords: Apolipoprotein B-100; Apolipoproteins B - blood; Atorvastatin; Biological and medical sciences; Blood Glucose - metabolism; Blood Pressure; Body Mass Index; Body Weight; Diabetes. Impaired glucose tolerance; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Fasting; Fatty Acids, Nonesterified - blood; Fish Oils - pharmacology; Heptanoic Acids - therapeutic use; Humans; Hydroxymethylglutaryl coenzyme A reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Hyperlipidemias - blood; Hyperlipidemias - drug therapy; Hyperlipidemias - physiopathology; Insulin - blood; Insulin Resistance; Kinetics; Male; Medical sciences; Middle Aged; Obesity; Obesity - blood; Obesity - complications; Obesity - physiopathology; Physiological aspects; Placebos; Pyrroles - therapeutic use; Risk factors; Type 2 diabetes; Australia; Human; Obesity; Pancreatic hormone; Nutrition disorder; Metabolic diseases; Male; Fish oil; Insulin; Apolipoprotein B; Target tissue resistance; Metabolic disorder; Atorvastatin; Kinetics; Dyslipemia